Pharyngeal neoplasm occurs when the cells in the pharynx become malignant and form an abnormal mass resulting in a tumor. Pharyngeal neoplasm (pharyngeal cancer, in other words) can occur in three areas of the pharynx viz. nasopharynx (the upper part, behind the nasal cavity), oropharynx (the middle part, behind the oral cavity), and hypopharynx (the bottom part, adjacent to the larynx).
The global pharyngeal neoplasm market can be segmented based on type, treatment, and geography. Based on type, the pharyngeal neoplasm market can be divided into nasopharyngeal cancer, oropharyngeal cancer, and hypopharyngeal cancer. Nasopharyngeal cancers are mostly squamous cell carcinomas. They are prevalent in Southeast Asia including countries such as China, Hong Kong, and Malaysia. Various symptoms of nasopharyngeal cancer are sore throat, bleeding nose, headache, and a lump in the neck. Oropharyngeal cancer develops at the base of the tongue, the tonsillar area, and the pharyngeal walls. Symptoms of the oropharyngeal cancer include cough; change in voice; a lump in the throat, the neck, and back of the mouth; and presence of white patches in the oropharynx. Hypopharyngeal cancer is the least common form of pharyngeal neoplasm. Poor nutrition and excessive drinking and smoking are a few risk factors for hypopharyngeal cancer. Symptoms include difficulty in swallowing, ear pain, sore throat, and a lump in the neck.
Based on treatment, the global pharyngeal neoplasm market can be segmented into primary resection & selective neck dissection, radiotherapy, chemotherapy, biological therapy, and hyperthermia. Radiotherapy includes stereotactic radiosurgery and proton beam therapy. Stereotactic radiosurgery treatment involves a high dosage of particular radiation to the tumor area in a single session or multiple sessions. The proton beam therapy method employs a beam of protons instead of X-rays to kill cancer cells. The beam of protons releases energy both before and after it hits the target. Moreover, it causes minor damage to tissues while passing through them. Proton beams release their energy after traveling a certain distance.
Based on geography, the global pharyngeal neoplasm market can be segmented into four major regions: North America, Europe, Asia Pacific, and Rest of World. North America dominates the global pharyngeal neoplasm market, followed by Europe. Key factors driving the market in these two regions are growing awareness about malignant effects of tumor among the people and availability of sophisticated and technologically advanced treatment options. According to a publication of the American Cancer Society, around 49,670 individuals in the U.S. were diagnosed with the oropharyngeal cancer in 2016. Additionally, increasing unhealthy lifestyle habits such as smoking and drinking is also contributing to growth of the pharyngeal neoplasm market in North America. Asia Pacific is one of the most promising markets for pharyngeal neoplasm, as the region has countries developing rapidly. Factors that propel the market in Asia Pacific are high prevalence of pharyngeal neoplasm; high population density in countries in Southeast Asia such as China, Malaysia, and Singapore; and government support for improvement in health care infrastructure in the region. Furthermore, presence of developing economies and easy penetration of the market in developing countries in Asia would drive the pharyngeal neoplasm market in Asia Pacific in the near future.
Several pharmaceutical companies are currently developing therapeutic treatments to reduce the malignant effects of the pharyngeal neoplasm. Some of the top players operating in the global pharyngeal neoplasm market are F. Hoffmann-La Roche Ltd., Cyclacel Pharmaceuticals, Inc., Biotech Pharmaceuticals Co., Ltd., Sanofi-Aventis, Prima BioMed Limited, and YM BioSciences, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.